Adicet Bio, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACET research report →
Companywww.adicetbio.com
Adicet Bio, Inc. , a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients.
- CEO
- Chen Schor
- IPO
- 2018
- Employees
- 152
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $72.54M
- P/E
- -0.77
- P/S
- 0.00
- P/B
- 0.60
- EV/EBITDA
- -0.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -80.35%
- ROIC
- -73.91%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-116,803,000 · 0.27%
- EPS
- $-16.95 · 20.35%
- Op Income
- $-122,114,000
- FCF YoY
- -3.73%
Performance & Tape
- 52W High
- $17.44
- 52W Low
- $6.01
- 50D MA
- $7.46
- 200D MA
- $9.57
- Beta
- 1.51
- Avg Volume
- 118.87K
Get TickerSpark's AI analysis on ACET
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 250,000 |
| Apr 27, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 250,000 |
| Feb 20, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 74,751 |
| Feb 19, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 74,268 |
| Feb 18, 26 | RA CAPITAL MANAGEMENT, L.P. | buy | 74,577 |
| Feb 17, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 0 |
| Feb 17, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 1,152,833 |
| Apr 7, 26 | ORBIMED ADVISORS LLC | sell | 29,319 |
| Apr 7, 26 | ORBIMED ADVISORS LLC | sell | 2,400 |
| Apr 8, 26 | ORBIMED ADVISORS LLC | sell | 32,523 |
Our ACET Coverage
We haven't published any research on ACET yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACET Report →